Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,649 | 659 | 99.9% |
| Education | $9.31 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,538 | 82 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,432 | 94 | $0 (2024) |
| Lundbeck LLC | $1,354 | 113 | $0 (2024) |
| Alkermes, Inc. | $1,175 | 73 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $1,011 | 55 | $0 (2023) |
| ABBVIE INC. | $807.12 | 45 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $702.53 | 37 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $536.20 | 42 | $0 (2022) |
| Allergan, Inc. | $368.71 | 30 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $334.91 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $390.51 | 16 | Teva Pharmaceuticals USA, Inc. ($185.16) |
| 2023 | $1,296 | 69 | Teva Pharmaceuticals USA, Inc. ($340.46) |
| 2022 | $1,623 | 92 | ABBVIE INC. ($240.79) |
| 2021 | $2,097 | 123 | Takeda Pharmaceuticals U.S.A., Inc. ($562.24) |
| 2020 | $1,108 | 79 | Takeda Pharmaceuticals U.S.A., Inc. ($296.90) |
| 2019 | $1,644 | 105 | Janssen Pharmaceuticals, Inc ($412.60) |
| 2018 | $1,395 | 92 | Alkermes, Inc. ($258.03) |
| 2017 | $1,107 | 86 | Janssen Pharmaceuticals, Inc ($333.23) |
All Payment Transactions
662 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.91 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Central Nervous System | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $34.84 | General |
| Category: Neuroscience | ||||||
| 03/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.35 | General |
| Category: PSYCHIATRY | ||||||
| 03/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Central Nervous System | ||||||
| 03/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: Central Nervous System | ||||||
| 03/14/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: Neurology | ||||||
| 02/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Central Nervous System | ||||||
| 02/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Neurology | ||||||
| 02/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.65 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Central Nervous System | ||||||
| 01/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: Neurology | ||||||
| 01/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Central Nervous System | ||||||
| 12/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Neuroscience | ||||||
| 11/28/2023 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Neuroscience | ||||||
| 11/10/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Neurology | ||||||
| 11/07/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: BH | ||||||
| 11/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: Central Nervous System | ||||||
| 11/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: Central Nervous System | ||||||
| 11/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 168 | 793 | $93,005 | $39,861 |
| 2022 | 6 | 175 | 886 | $85,693 | $38,403 |
| 2021 | 6 | 176 | 715 | $70,388 | $34,161 |
| 2020 | 5 | 195 | 745 | $87,180 | $40,074 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 49 | 279 | $27,900 | $14,250 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 156 | $14,040 | $7,984 | 56.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 192 | $17,096 | $7,201 | 42.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 88 | $14,576 | $5,210 | 35.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 51 | $11,599 | $3,228 | 27.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 13 | $3,322 | $1,184 | 35.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 14 | $4,471 | $802.75 | 18.0% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 48 | 266 | $26,590 | $14,136 | 53.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 27 | 393 | $33,257 | $11,716 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 167 | $15,030 | $9,121 | 60.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 21 | $4,618 | $1,391 | 30.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 17 | 22 | $3,462 | $1,159 | 33.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 17 | $2,736 | $880.07 | 32.2% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 51 | 241 | $24,100 | $12,985 | 53.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 181 | $16,290 | $10,433 | 64.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 23 | 224 | $18,355 | $6,524 | 35.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 14 | 22 | $4,642 | $1,665 | 35.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 23 | $3,434 | $1,302 | 37.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 18 | 24 | $3,567 | $1,252 | 35.1% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 59 | 269 | $26,900 | $12,990 | 48.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 66 | 230 | $20,700 | $11,319 | 54.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 24 | 184 | $26,287 | $10,462 | 39.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 27 | 35 | $9,422 | $3,741 | 39.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 19 | 27 | $3,871 | $1,562 | 40.3% |
About Dr. Roger Levine, MD
Dr. Roger Levine, MD is a Psychiatry healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245241181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Levine, MD has received a total of $10,659 in payments from pharmaceutical and medical device companies, with $390.51 received in 2024. These payments were reported across 662 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($10,649).
As a Medicare-enrolled provider, Levine has provided services to 714 Medicare beneficiaries, totaling 3,139 services with total Medicare billing of $152,498. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Syracuse, NY
- Active Since 08/09/2006
- Last Updated 06/21/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245241181
Products in Payments
- REXULTI (Drug) $1,637
- TRINTELLIX (Drug) $1,257
- VRAYLAR (Drug) $1,164
- ARISTADA (Drug) $782.39
- SPRAVATO (Drug) $745.92
- INVEGA SUSTENNA (Drug) $631.99
- LATUDA (Drug) $536.20
- ABILIFY MAINTENA (Drug) $470.86
- Aristada 441 mg (Drug) $370.03
- Trintellix (Drug) $354.26
- HETLIOZ (Drug) $295.15
- Austedo XR (Drug) $290.01
- AUSTEDO (Drug) $247.74
- Auvelity (Drug) $196.43
- VYVANSE (Drug) $165.04
- UZEDY (Drug) $164.78
- APLENZIN (Drug) $158.40
- BRINTELLIX (Drug) $116.34
- INVEGA TRINZA (Drug) $107.72
- PERSERIS (Drug) $93.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Syracuse
Steven Naprawa, Md, MD
Psychiatry — Payments: $454,605
Dr. Michael Pratts, M.d, M.D
Psychiatry — Payments: $210,670
Dr. Andrew Kaufman, M.d, M.D
Psychiatry — Payments: $16,140
Saundra Barnett-Reyes, M.d, M.D
Psychiatry — Payments: $8,078
Dr. Riaz Syed, M.d, M.D
Psychiatry — Payments: $3,786
Thomas Schwartz, M.d, M.D
Psychiatry — Payments: $3,324